CytoMed Therapeutics (GDTC) vs Lisata Therapeutics (LSTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Lisata Therapeutics (LSTA) has outperformed CytoMed Therapeutics (GDTC) over the past year, losing 52.6% versus a loss of 54.6%. Lisata Therapeutics is the larger company by market cap ($12.5 million vs $11.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GDTC | LSTA |
|---|---|---|
| Share price | $0.92 | $1.16 |
| Market cap | $10.98M | $12.48M |
| 1-day change | -6.10% | -1.28% |
| YTD return | -26.59% | -37.10% |
| 1-year return | -54.63% | -52.63% |
| 5-year return | — | -93.61% |
| EPS (TTM) | $-0.23 | $-1.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.68 | $5.07 |
| 52-week low | $0.68 | $0.99 |
| Distance from 52-week high | -75.00% | -77.22% |
| Average volume | 78.41K | 291.91K |
| Shares outstanding | 11.93M | 10.80M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
GDTC vs LSTA FAQ
Which is bigger, CytoMed Therapeutics or Lisata Therapeutics?
Lisata Therapeutics (LSTA) is larger, with a market capitalization of $12.48M compared with $10.98M for CytoMed Therapeutics (GDTC).
Which stock has performed better over the past year, GDTC or LSTA?
LSTA returned -52.63% over the past 12 months, compared with -54.63% for GDTC (price return, excluding dividends). Past performance does not predict future results.
Are CytoMed Therapeutics and Lisata Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.